AR and cancer: They showed that an androgen receptor-derived stapled peptide, called Rh-2025u, which has been shown to interfere in the complex assembly in cancer-associated fibroblasts and prostate tumor cells, can overcome the shortcomings of current still unsatisfactory therapies [248].